Thoracic Surgery by the Medtronic Hugo™ Robotic System

Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how well the Medtronic Hugo™ robotic system works for patients with thoracic cancer undergoing minimally invasive surgery. The goal is to see the early results and functional outcomes of surgeries performed using this advanced robotic technology. The Hugo™ system is designed to make robotic surgery more accessible, allowing surgeons to perform precise operations in tight spaces, which can lead to quicker recovery times for patients.

To participate in this trial, you need to be between 18 and 80 years old, have a body mass index (BMI) under 35, and be a good candidate for minimally invasive surgery. You also need to be willing to give your consent to take part in the study. If you have certain health conditions or if you're pregnant, you may not be eligible. If you join the trial, you can expect to be monitored closely for your recovery and any side effects, helping researchers learn more about this innovative approach to treating thoracic cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age between 18 - 80 years
• • 2. Body mass index \<35 kg/m2
• • 3. Suitable for minimally invasive surgery
• • 4. Willingness to participate as demonstrated by giving informed consent
• Exclusion Criteria:
• • 1. Contraindication to general anaesthesia
• • 2. Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
• • 3. Untreated active infection
• • 4. Non-correctable coagulopathy
• • 5. Emergency surgery
• • 6. Vulnerable population (e.g. mentally disabled, pregnancy)